Passage BIO Files 8-K
Ticker: PASG · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1787297
Sentiment: neutral
Topics: sec-filing, 8-k, reporting
TL;DR
Passage BIO filed a routine 8-K, no major news.
AI Summary
Passage BIO, Inc. filed an 8-K on June 23, 2025, reporting other events and financial statements. The filing does not contain specific details about new material events, acquisitions, or financial performance beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates Passage BIO, Inc. is adhering to its reporting obligations with the SEC, but it does not disclose any new material information that would immediately impact investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and financial statements, with no indication of significant new risks or material adverse events.
Key Numbers
- 001-39231 — SEC File Number (Identifies the specific SEC filing for Passage BIO, Inc.)
- 82-2729751 — IRS Employer Identification No. (Tax identification number for Passage BIO, Inc.)
Key Players & Entities
- Passage BIO, Inc. (company) — Registrant
- June 23, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Philadelphia, PA (location) — Address of principal executive offices
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the provided text does not detail the specific nature of these events.
Are there any new financial statements or exhibits attached to this 8-K?
Yes, 'Financial Statements and Exhibits' are listed as item information, but the content of these documents is not detailed in the provided text.
Has Passage BIO, Inc. changed its principal executive offices?
The filing lists the current principal executive offices as One Commerce Square, 2005 Market Street, 39th Floor, Philadelphia, PA 19103, and does not indicate a change.
What is the fiscal year end for Passage BIO, Inc.?
The fiscal year end for Passage BIO, Inc. is December 31 (1231).
What is the Standard Industrial Classification (SIC) code for Passage BIO, Inc.?
The SIC code for Passage BIO, Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Passage BIO, Inc. (PASG).